Apurwa Karki
Internal Medicine · Fort Wayne, INNPI 1629467105
Payments from drug & device makers
Across 28 payments — averaging $117.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pulmonx Corporation$1K
- Boston Scientific$979
- Johnson & Johnson$924
- AstraZeneca$82
- Grifols USA, LLC$36
- United Therapeutics Corporation$23
- plus $61 from 4 others
What the payments were for
- Travel & lodging$2,73383%
- Food & beverage$54517%
- Education$231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pulmonx Corporation | 3 | $1,196 |
| Boston Scientific | 11 | $979 |
| Johnson & Johnson | 4 | $924 |
| AstraZeneca | 3 | $82 |
| Grifols USA, LLC | 2 | $36 |
| United Therapeutics Corporation | 1 | $23 |
| Vapotherm Inc | 1 | $16 |
| Pfizer | 1 | $16 |
| Olympus America Inc. | 1 | $15 |
| Insmed, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEPHYR ENDOBRONCHIAL VALVE$1,196
- MONARCH$891
- EXPECT$679
How this compares
$3,300 in reported general payments places this provider in the 85th percentile of 1,747 internal medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 79 | $62,891 |
| Spiriva RespimatTiotropium Bromide | 16 | $8,155 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $6,696 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 14 | $6,552 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $6,372 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 62 | $2,843 |
| Azithromycin | 21 | $247 |
| Montelukast Sodium | 20 | $114 |
| Prednisone | 25 | $108 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Fort Wayne
- David IloFort Wayne$86K
- Anuradha KolliparaFort Wayne$30K
- Sumona KabirFort Wayne$28K
- Robert BuynakValparaiso$24.2M
- Mohammed AllawNewburgh$3.6M
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- George CornettFranklin$1.3M
- Ajita NarayanLafayette$951K
- Abhinav SinghGreenwood$738K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.